leadf
logo-loader
viewMarrone Bio Innovations

Marrone Bio Innovations new CEO Kevin Helash reveals uptick in quarterly earnings

Marrone Bio Innovations Inc (NASDAQ:MBII) new CEO Kevin Helash reveals uptick in second quarterly earnings, that doubled year-over-year.

Helash, who joins Marrone Bio from biological crop input provider Agrinos, says growing sales of its row crop treatments and other fungicides lead to the increase. He adds he's excited to take the company to its next level of success.

Quick facts: Marrone Bio Innovations

Price: 1.18 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $176.26 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Marrone Bio Innovations announces alliance with South American company...

Marrone Bio Innovations (NASDAQ: MBII) Chief Commerical Officer Kevin Hammill joined Steve Darling from Proactive to share news the company has taken a step forward on global expansion by announcing an alliance with the South American company Rizobacter to distribute novel plant health and crop...

2 days, 16 hours ago

2 min read